HER2-Positive Neuroendocrine Breast Cancer: Case Report and Review of Literature

Publisher： Karger

E-ISSN： 1661-3805|11|6|424-426

ISSN： 1661-3791

Source： Breast Care, Vol.11, Iss.6, 2016-12, pp. : 424-426

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systemic Treatment Options for HER2-Positive Breast Cancer Patients with Brain Metastases beyond Trastuzumab: A Literature Review

By  

Breast Care, Vol. 12, Iss. 3, 2017-06 ,pp. : 168-171

Karger

Access to resources Recommend Favorite

Effectiveness of Pertuzumab, Trastuzumab, and Docetaxel Combination Neoadjuvant Chemotherapy for HER2-Positive Inflammatory Breast Cancer: A Case Report

By  

Breast Care, Vol. 12, Iss. 1, 2017-02 ,pp. : 45-47

Karger

Access to resources Recommend Favorite

Therapy Standards in HER2-Positive Breast Cancer

By  

Breast Care, Vol. 11, Iss. 2, 2016-04 ,pp. : 148-150

Karger

Access to resources Recommend Favorite

Anti-HER2 Therapy Beyond Second-Line for HER2- Positive Metastatic Breast Cancer: A Short Review and Recommendations for Several Clinical Scenarios from a Spanish Expert Panel

By  

Breast Care, Vol. 11, Iss. 2, 2016-02 ,pp. : 133-138

Karger

Access to resources Recommend Favorite

Breast Tuberculosis after Chest Trauma - a Case Report and Review of the Literature

By  

Breast Care, Vol. 11, Iss. 3, 2016-06 ,pp. : 200-203

Karger

Access to resources Recommend Favorite